Rate My Professor Jeffrey Kordower

Prior to joining ASU in 2021, Kordower spent over 30 years at Rush University Medical Center in Chicago as the Alla V. and Solomon Jesmer Professor of Neurological Sciences. He also held positions as Director’s Scholar and Professor of Neurodegeneration at the Van Andel Institute, consulted for the FDA and pharmaceutical companies including Takeda and Biogen, and served on numerous editorial boards as associate editor for Neurobiology of Aging. He has authored over 400 research papers, edited books, and chapters. Key contributions include the first demonstration that dopaminergic grafts survive, innervate, and form synapses in Parkinson’s disease patients, and the observation that long-term grafts develop Lewy bodies. His laboratory’s research has advanced to seven clinical trials. Notable publications include "Tau, amyloid-β and α-synuclein co-pathologies synergistically enhance neuroinflammation and hippocampal neuron loss" (2026, Neurobiology of Disease), "The Management of Parkinson's Disease Before, during and after Pregnancy—an MDS Scientific Issues Committee Review" (2026, Movement Disorders Clinical Practice), and "Disease-modifying, multidimensional efficacy of putaminal CaV1.3-shRNA gene therapy in aged parkinsonism male and female macaques" (2025, Molecular Therapy). Kordower has received the Huntington’s Disease Society of America’s Award of Excellence in Medicine, John Douglas French Fellowship for the Study of Alzheimer's Disease, Bernard Sandberg Memorial Award for Brain Repair, and an Honorary Doctor of Science from the City University of New York.